Delayed localized hypersensitivity reactions to COVID‐19 mRNA vaccines: a 6‐month retrospective study
Open Access
- 26 August 2021
- journal article
- letter
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (1) , 157-158
Abstract
The clinical trials of the two novel COVID-19 vaccines (Pfizer/BioNTech; Moderna) reported delayed local injection site reactions.1,2 Since vaccination rates increase, awareness of the adverse reactions is needed. This research letter reports a series of delayed localized hypersensitivity reactions to mRNA SARS-CoV-2 vaccines with histopathologic confirmation.Keywords
This publication has 5 references indexed in Scilit:
- Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 casesJournal of the American Academy of Dermatology, 2021
- Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 VaccineJAMA Dermatology, 2021
- Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2New England Journal of Medicine, 2021
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineNew England Journal of Medicine, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020